Artiva Biotherapeutics, Inc. License Agreements
12 Contracts & Agreements
- Amendment to Selected Product License Agreement (AB-201), dated September 6, 2023, by and between the Registrant and GC Cell Corporation (Filed With SEC on June 28, 2024)
- Selected Product License Agreement (AB-201), dated September 29, 2020, by and between the Registrant and GC Cell Corporation (Filed With SEC on June 28, 2024)
- Selected Product License Agreement (AB-101), dated November 21, 2019, by and between the Registrant and GC Cell Corporation (Filed With SEC on June 28, 2024)
- Amendment No. 1 to Option and License Agreement, dated June 23, 2020, by and between the Registrant and GC Cell Corporation (Filed With SEC on June 28, 2024)
- Option and License Agreement, dated September 4, 2019, by and between the Registrant and GC Cell Corporation (f/k/a GC Lab Cell Corporation) (Filed With SEC on June 28, 2024)
- First Amendment to License Agreement, dated May 9, 2022, by and between the Registrant and ARE-SD Region No. 37, LLC (Filed With SEC on June 6, 2022)
- Selected Product License Agreement (AB-202), dated March 24, 2021, by and between the Registrant and Green Cross LabCell Corporation (Filed With SEC on April 8, 2021)
- Merck Partnered Product Research Services and License Agreement, dated January 27, 2021, by and between the Registrant and Green Cross LabCell Corporation (Filed With SEC on April 8, 2021)
- Selected Product License Agreement (AB-201), dated September 29, 2020, by and between the Registrant and Green Cross LabCell Corporation (Filed With SEC on April 8, 2021)
- Selected Product License Agreement (AB-101), dated November 21, 2019, by and between the Registrant and Green Cross LabCell Corporation (Filed With SEC on April 8, 2021)
- Amendment No. 1 to Option and License Agreement, dated June 23, 2020, by and between the Registrant and Green Cross LabCell Corporation (Filed With SEC on April 8, 2021)
- Option and License Agreement, dated September 4, 2019, by and between the Registrant and Green Cross LabCell Corporation (Filed With SEC on April 8, 2021)
